Ischemic tolerance in the brain

Acta Physiologica Hungarica

Volumn 92, Issue 1, 2005, Pages 67-92

  Kapinya, Krisztian J ^a,b  

^a HUMBOLDT UNIVERSITY   (Germany)

^b ALBERT EINSTEIN MEDICAL CENTER   (United States)

Author keywords

Cell culture; Cerebral ischemia; Gerbil; Mouse; Preconditioning; Rat; Stroke

Indexed keywords

PHOSPHOTRANSFERASE; TRANSCRIPTION FACTOR;

ADAPTATION; BRAIN ISCHEMIA; BRAIN PROTECTION; CELL CULTURE; CROSS TOLERANCE; DEGENERATIVE DISEASE; EXPERIMENTAL MODEL; EXPERIMENTATION; GERBIL; IN VIVO STUDY; ISCHEMIC TOLERANCE; MOLECULAR BIOLOGY; MOUSE; NERVE CELL EXCITABILITY; NONHUMAN; RAT; REVIEW; STROKE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN; BRAIN ISCHEMIA; CELL DEATH; GENE EXPRESSION; GERBILLINAE; ISCHEMIC PRECONDITIONING; MAP KINASE SIGNALING SYSTEM; MICE; RATS; TRANSCRIPTION FACTORS;

EID: 20444362766     PISSN: 0231424X     EISSN: None     Source Type: Journal    
DOI: 10.1556/APhysiol.92.2005.1.9     Document Type: Review

References (200)

1. Abate C, Patel L, Rauscher FJ, Curran T: Redox regulation of Fos and Jun DNA-binding activity in vitro. Science 249, 1157-1161 (1990)
2. Ahn S, Riccio A, Ginty DD: Spatial considerations for stimulus-dependent transcription in neurons. Annu. Rev. Physiol. 62, 803-823 (2000)
3. Alam J, Den Z: Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J. Biol. Chem. 267, 21894-21900 (1992)
4. Alessandrini A, Namura S, Moskowitz MA, Bonventre JV: MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia. Proc. Natl. Acad. Sci. USA. 96, 12866-12869 (1999)
5. An G, Lin TN, Liu JS, Xue JJ, He YY, Hsu CY: Expression of c-fos and c-jun family genes after focal cerebral ischemia. Ann. Neurol. 33, 457-464 (1993)
6. Angel P, Karin M: The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim. Biophys. Acta 1072, 129-157 (1991)
7. Ascher P, Nowak L: Electrophysiological studies of NMDA receptors. Trends Neursci. 10, 284-288 (1987)
8. Astrup J, Siesjo BK, Symon L: Thresholds in cerebral ischemia - the ischemic penumbra. Stroke 12, 723-725 (1980)
9. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ: Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 28, 1233-1244 (1997)
10. Barone FC, Arvin B, White RF, Miller A, Webb CL, Willette RN, Lysko PG, Feuerstein GZ: Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. Stroke 29, 1937-1950 (1998)
11. Beck T, Lindholm D, Castren E, Wree A: Brain-derived neurotrophic factor protects against ischemic cell damage in rat hippocampus. J. Cereb. Blood Flow Metab. 14, 689-692 (1994)
12. Belayev L, Ginsberg MD, Alonso OF, Singer JT, Zhao W, Busto R: Bilateral ischemic tolerance of rat hippocampus induced by prior unilateral transient focal ischemia: relationship to c-fos mRNA expression. Neuroreport 8, 55-59 (1996)
13. Bergeron M, Gidday JM, Yu AY, Semenza GL, Ferriero DM, Sharp FR: Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Annn Neurol. 48, 285-296 (2000)
14. Bernaudin M, Nedelec AS, Divoux D, MacKenzie ET, Petit E, Schumann-Bard P: Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22, 393-403 (2002)
15. Blondeau N, Widmann C, Lazdunski M, Heurteaux C: Activation of the nuclear factor-kappaB is a key event in brain tolerance. J. Neurosci. 21, 4668-4677 (2001)
16. Borrello S, Demple B: NF kappa B-independent transcriptional induction of the human manganous superoxide dismutase gene. Arch. Biochem. Biophys. 348, 289-394 (1997)
17. Borsello T, Clarke PG, Hirt L, Vercelli A, Repici M, Schorderet DF, Bogousslavsky J, Bonny C: A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia. Nat. Med. 9, 1180-1186 (2003)
18. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W: Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J. Cereb. Blood Flow Metab. 8, 474-485 (1988)
19. Bruer U, Weih MK, Isaev NK, Meisel A, Ruscher K, Bergk A, Trendelenburg G, Wiegand F, Victorov IV, Dirnagl U: Induction of tolerance in rat cortical neurons: hypoxic preconditioning. FEBS Lett. 414, 117-421 (1997)
20. Buchan AM, Xue D, Slivka A: A new model of temporary focal neocortical ischemia in the rat. Stroke 23, 273-279 (1992)
21. Campbell SE, Nasir L, Argyle DJ, Bennett D: Molecular cloning and characterization of canine metalloproteinase-9 gene promoter. Gene 273, 81-87 (2001)
22. Cao G, Pei W, Ge H, Liang Q, Luo Y, Sharp FR, Lu A, Ran R, Graham SH, Chen J: In vivo delivery of a Bcl-xL fusion protein containing the TAT protein transduction domain protects against ischemic brain injury and neuronal apoptosis. J. Neurosci. 22, 5423-5431 (2002)
23. Carmeliet P, Dor Y, Herbert J-M, Fukumura D, Brusselmans K, Dewerchin M, Neeman M, Bono F, Abramovitch R, Maxwell P, Koch CJ, Ratcliffe P, Moons L, Jain RK, Collen D, Keshet E: Role of HIF-1α in hypoxia-mediated apoptosis, cell proliferation, and tumour angiogenesis. Nature 394, 485-490 (1998)
24. Chan H, Bartos DP, Owen-Schaub LB: Activation-dependent transcriptional regulation of the human Fas promoter requires NF-kappaB p50-p65 recruitment. Mol. Cell. Biol. 19, 2098-2108 (1999)
25. Chan PH: Role of oxidants in ischemic brain damage. Stroke 27, 1124-1129 (1996)
26. Cheng B, Christakos S, Mattson MP: Tumor necrosis factors protect neurons against metabolic-excitotoxic insults and promote maintenance of calcium homeostasis. Neuron 12, 139-153 (1994)
27. Chilov D, Kukk E, Taira S, Jeltsch M, Kaukonen J, Palotie A, Joukov V, Alitalo K: Genomic organization of human and mouse genes for vascular endothelial growth factor C. J. Biol. Chem. 272, 25176-25183 (1997)
28. Collart MA, Baeuerle P, Vassalli P: Regulation of tumor necrosis factor alpha transcription in macrophages: involvement of four kappa B-like motifs and of constitutive and inducible forms of NF-kappa B. Mol. Cell. Biol. 10, 1498-1506 (1990)
29. Connolly ES Jr, Winfree CJ, Springer TA, Naka Y, Liao H, Yan SD, Stern DM, Solomon RA, Gutierrez-Ramos JC, Pinsky DJ: Cerebral protection in homozygous null ICAM-1 mice after middle cerebral artery occlusion. Role of neutrophil adhesion in the pathogenesis of stroke. J. Clin. Invest. 97, 209-216 (1996)
30. Cormier-Regard S, Nguyen SV, Claycomb WC: Adrenomedullin gene expression is developmentally regulated and induced by hypoxia in rat ventricular cardiac myocytes. J. Biol. Chem. 273, 17787-17792 (1998)
31. Crumrine RC, Thomas AL, Morgan PF: Attenuation of p53 expression protects against focal ischemic damage in transgenic mice. J. Cereb. Blood Flow Metab. 14, 887-891 (1994)
32. D'Mello SR, Heinrich G: Structural and functional identification of regulatory regions and cis elements surrounding the nerve growth factor gene promoter. Mol. Brain Res. 1, 255-264 (1991)
33. Dirnagl U, Iadecola C, Moskowitz MA: Ischemic tolerance and endogenous neuroprotection. Trends Neurosci. 26, 248-254 (2003)
34. Dogan A, Suzuki Y, Koketsu N, Osuka K, Saito K, Takayasu M, Shibuya M, Yoshida J: Intravenous infusion of adrenomedullin and increase in regional cerebral blood flow and prevention of ischemic brain injury after middle cerebral artery occlusion in rats. J. Cereb. Blood Flow Metab. 17, 19-25 (1997)
35. Dringen R, Pfeiffer B, Hamprecht B: Synthesis of the antioxidant glutathione in neurons: supply by astrocytes of CysGly as precursor for neuronal glutathione. J. Neurosci. 19, 562-569 (1999)
36. Du ZY, Hicks M, Winlaw D, Spratt P, Macdonald P: Ischemic preconditioning enhances donor lung preservation in the rat. J. Heart Lung Transplant. 15, 1258-1267 (1996)
37. Endres M, Fan G, Hirt L, Fujii M, Matsushita K, Liu X, Jaenisch R, Moskowitz MA: Ischemic brain damage in mice after selectively modifying BDNF or NT4 gene expression. J. Cereb. Blood Flow Metab. 20, 139-144 (2000)
38. Enlimomab Acute Stroke Trial Investigators. Use of anti-ICAM-1 therapy in ischemic stroke: results of the Enlimomab Acute Stroke Trial. Neurology 57, 1428-1434 (2001)
39. Feldser D, Agani F, Iyer NV, Pak B, Ferreira G, Semenza GL: Reciprocal postive regulation of hypoxia-inducible factor 1 and insulin-like growth factor 2. Cancer Res. 59, 3915-3918 (1999)
40. Freshney NW, Rawlinson L, Guesdon F, Jones E, Cowley S, Hsuan J, Saklatvala J: Interleukin-1 activates a novel protein kinase cascade that results in the phosphorylation of Hsp27. Cell 78, 1039-1049 (1994)
41. Geiger JR, Melcher T, Koh DS, Sakmann B, Seeburg PH, Jonas P, Monyer H: Relative abundance of subunit mRNAs determines gating and Ca2+ permeability of AMPA receptors in principal neurons and interneurons in rat CNS. Neuron 15, 193-204 (1995)
42. Geimonen E, Jiang W, Ali M, Fishman GI, Garfield RE, Andersen J: Activation of protein kinase C in human uterine smooth muscle induces connexin-43 gene transcription through an AP-1 site in the promoter sequence. J. Biol. Chem. 271, 23667-23674 (1996)
43. Glazier SS, O'Rourke DM, Graham DI, Welsh FA: Induction of ischemic tolerance following brief focal ischemia in rat brain. J. Cereb. Blood Flow Metab. 14, 545-553 (1994)
44. Goldberg MP, Choi DW: Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J. Neurosci. 13, 3510-3424 (1993)
45. Gonzalez-Zulueta M, Feldman AB, Klesse LJ, Kalb RG, Dillman JF, Parada LF, Dawson TM, Dawson VL: Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning. Proc. Natl. Acad. Sci. USA. 97, 436-441 (2000)
46. Grabb MC, Choi DW: Ischemic tolerance in murine cortical cell culture: critical role for NMDA receptors. J. Neurosci. 19, 1657-1662 (1999)
47. Gu Z, Jiang Q, Zhang G, Cui Z, Zhu Z: Diphosphorylation of extracellular signal-regulated kinases and c-Jun N-terminal protein kinases in brain ischemic tolerance in rat. Brain Res. 860, 157-160 (2000)
48. Gu Z, Jiang Q, Zhang G: Extracellular signal-regulated kinase and c-Jun N-terminal protein kinase in ischemic tolerance. Neuroreport 12, 3487-3491 (2001)
49. Hara T, Hamada J, Yano S, Morioka M, Kai Y, Ushio Y: CREB is required for acquisition of ischemic tolerance in gerbil hippocampal CA1 region. J. Neurochem. 86, 805-814 (2003)
50. Herdegen T, Skene P, Bahr M: The c-Jun transcription factor - bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20, 227-231 (1997)
51. Herdegen T, Waetzig V: AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20, 2424-2437 (2001)
52. Heurteaux C, Lauritzen I, Widmann C, Lazdunski M: Essential role of adenosine, adenosine A1 receptors, and ATP-sensitive K+ channels in cerebral ischemic preconditioning. Proc. Natl. Acad. Sci USA 92, 4666-4670 (1995)
53. Hirt L, Badaut J, The venet J, Granziera C, Regli L, Maurer F, Bonny C, Bogousslavsky J: D-JNKI1, a cell-penetrating c-Jun-N-terminal kinase inhibitor, protects against cell death in severe cerebral ischemia. Stroke 35, 1738-1743 (2004)
54. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I, Pepin N, Lacoste J, Nguyen H, Bensi G et al.: Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol. Cell Biol. 13, 6231-6240 (1993)
55. Hollmann M, Hartley M, Heinemann S: Ca2+ permeability of KA-AMPA-gated glutamate receptor channels depends on subunit composition. Science 252, 851-853 (1991)
56. Hu J, Discher DJ, Bishopric NH, and Webster KA: Hypoxia regulates expression of the endothelin-1 gene through a proximal hypoxia-inducible factor-1 binding site on the antisense strand. Biochem. Biophys. Res. Commun. 245, 894-899 (1998)
57. Huang TT, Vinci JM, Lan L, Jeffrey JJ, Wilcox BD: Serotonin-inducible transcription of interleukin-1alpha in uterine smooth muscle cells requires an AP-1 site: cloning and partial characterization of the rat IL-1alpha promoter. Mol. Cell Endocrinol. 152, 21-35 (1999)
58. Huang Z, Huang PL, Panahian N, Dalkara T, Fishman MC, Moskowitz MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science 265, 1883-1885 (1994)
59. Huot J, Houle F, Spitz DR, Landry J: HSP27 phosphorylation-mediated resistance against actin fragmentation and cell death induced by oxidative stress. Cancer. Res. 56, 273-279 (1996)
60. Iadecola C, Niwa K, Nogawa S, Zhao X, Nagayama M, Araki E, Morham S, Ross ME: Reduced susceptibility to ischemic brain injury and N-methyl-D-aspartate- mediated neurotoxicity in cyclooxygenase-2-deficient mice. Proc. Natl. Acad. Sci. USA 98, 1294-1299 (2001)
61. Iadecola C, Zhang F, Casey R, Nagayama M, Ross ME: Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. J. Neurosci. 17, 9157-9164 (1997)
62. Iadecola C, Zhang F, Xu X: Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. J. Physiol. 268, R286-292 (1995)
63. Iihara K, Hashimoto N, Tsukahara T, Sakata M, Yanamoto H, Taniguchi T: Platelet-derived growth factor-BB, but not -AA, prevents delayed neuronal death after forebrain ischemia in rats. J Cereb. Blood Flow Metab. 17, 1097-1106 (1997)
64. Janssen-Heininger YM, Poynter ME, Baeuerle PA: Recent advances towards understanding redox mechanisms in the activation of nuclear factor kappaB. Free Radic. Biol. Med. 28, 1317-1327 (2000)
65. Jaworski J, Biedermann IW, Lapinska J, Szklarczyk A, Figiel I, Konopka D, Nowicka D, Filipkowski RK, Hetman M, Kowalczyk A, Kaczmarek L: Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus. J. Biol. Chem. 274, 28106-28112 (1999)
66. Jiang B-H, Rue E, Wang GL, Roe R, and Semenza GL: Dimerization, DNA binding, and transactivation properties of hypoxia-inducible factor 1. J. Biol. Chem. 271, 17771-17778 (1996)
67. Jones NM, Bergeron M: Hypoxia-induced ischemic tolerance in neonatal rat brain involves enhanced ERK1/2 signaling. J. Neurochem. 89, 157-167 (2004)
68. Jovin TG, Yonas H, Gebel JM, Kanal E, Chang YF, Grahovac SZ, Goldstein S, Wechsler LR: The cortical ischemic core and not the consistently present penumbra is a determinant of clinical outcome in acute middle cerebral artery occlusion. Stroke 34, 2426-2433 (2003)
69. Kaltschmidt C, Kaltschmidt B, Baeuerle PA: Stimulation of ionotropic glutamate receptors activates transcription factor NF-kappa B in primary neurons. Proc. Natl. Acad. Sci. USA 92, 9618-9622 (1995)
70. Kapinya JK, Herwig U, Harms C, Blei K, Katchanov J, Dirnagl U, Hortnagl H: Role of NAD(P)H:quinone oxidoreductase in the progression of neuronal cell death in vitro and following cerebral ischemia in vivo. J. Neurochem. 84, 1028-1039 (2003)
71. Kapinya K, Penzel R, Sommer C, Kiessling M: Temporary changes of the AP-1 transcription factor binding activity in the gerbil hippocampus after transient global ischemia, and ischemic tolerance induction. Brain Res. 872, 282-293 (2000)
72. Kapinya KJ, Lowl D, Futterer C, Maurer M, Waschke KF, Isaev NK, Dirnagl U: Tolerance against ischemic neuronal injury can be induced by volatile anesthetics and is inducible NO synthase dependent. Stroke 33, 1889-1898 (2002)
73. Kapinya KJ, Prass K, Dirnagl U: Isoflurane induced prolonged protection against cerebral ischemia in mice: a redox sensitive mechanism? Neuroreport 13, 1431-1435 (2002)
74. Kato H, Liu Y, Araki T, Kogure K: Temporal profile of the effects of pretreatment with brief cerebral ischemia on the neuronal damage following secondary ischemic insult in the gerbil: cumulative damage and protective effects. Brain Res. 553, 238-242 (1991)
75. Kawahara N, Ide T, Saito N, Kawai K, Kirino T: Propentofylline potentiates induced ischemic tolerance in gerbil hippocampal neurons via adenosine receptor. J. Cereb. Blood Flow Metab. 18, 472-475 (1998)
76. Keinanen R, Vartiainen N, Koistinaho J: Molecular cloning and characterization of the rat inducible nitric oxide synthase (iNOS) gene. Gene 234, 297-305 (1999)
77. Keller JN, Kindy MS, Holtsberg FW, St Clair DK, Yen HC, Germeyer A, Steiner SM, Bruce-Keller AJ, Hutchins JB, Mattson MP: Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation, and mitochondrial dysfunction. J. Neurosci. 18, 687-197 (1998)
78. Khachigian LM, Resnick N, Gimbrone MA Jr, Collins T: Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J. Clin. Invest. 96, 1169-1175 (1995)
79. Khaspekov L, Shamloo M, Victorov I, Wieloch T: Sublethal in vitro glucose-oxygen deprivation protects cultured hippocampal neurons against a subsequent severe insult. Neuroreport 9, 1273-1276 (1998)
80. Kiessling M, Stumm G, Xie Y, Herdegen T, Aguzzi A, Bravo R, Gass P: Differential transcription and translation of immediate early genes in the gerbil hippocampus after transient global ischemia. J. Cereb. Blood Flow Metab. 13, 914-924 (1993)
81. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H: Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95, 189-197 (2000)
82. Kirino T, Sano K: Selective vulnerability in the gerbil hippocampus following transient ischemia. Acta Neuropathol. (Berl). 62, 201-208 (1984)
83. Kirino T, Tsujita Y, and Tamura A: Induced tolerance to ischemia in gerbil hippocampal neurons. J. Cereb. Blood Flow Metab. 11, 299-307 (1991)
84. Kirino T: Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 239, 57-69 (1982)
85. Kirino T: Ischemic tolerance. J. Cereb. Blood Flow Metab. 22, 1283-1296 (2002)
86. Kitagawa K, Matsumoto M, Tagaya M, Hata R, Ueda H, Niinobe M, Handa N, Fukunaga R, Kimura K, Mikoshiba K, et al.: 'Ischemic tolerance' phenomenon found in the brain. Brain Res. 528, 21-24 (1990)
87. Kitagawa K, Matsumoto M, Tagaya M, Kuwabara K, Hata R, Handa N, Fukunaga R, Kimura K, Kamada T: Hyperthermia-induced neuronal protection against ischemic injury in gerbils. J. Cereb Blood Flow Metab. 11, 449-452. (1991)
88. Kobayashi S, Harris VA, Welsh FA: Spreading depression induces tolerance of cortical neurons to ischemia in rat brain. J. Cereb. Blood Flow Metab. 15, 721-727 (1995)
89. Krohn K, Rozovsky I, Wals P, Teter B, Anderson CP, Finch CE: Glial fibrillary acidic protein transcription responses to transforming growth factor-beta1 and interleukin-1beta are mediated by a nuclear factor-1-like site in the near-upstream promoter. J. Neurochem. 72, 1353-1361 (1999)
90. Kuan CY, Whitmarsh AJ, Yang DD, Liao G, Schloemer AJ, Dong C, Bao J, Banasiak KJ, Haddad GG, Flavell RA, Davis RJ, Rakic P: A critical role of neural-specific JNK3 for ischemic apoptosis. Proc. Natl. Acad. Sci. USA 100, 15184-15189 (2003)
91. Kume M, Yamamoto Y, Saad S, Gomi T, Kimoto S, Shimabukuro T, Yagi T, Nakagami M, Takada Y, Morimoto T, Yamaoka Y: Ischemic preconditioning of the liver in rats: implications of heat shock protein induction to increase tolerance of ischemia-reperfusion injury. J. Lab. Clin. Med. 128, 251-258 (1996)
92. Lavrovsky Y, Schwartzman ML, Levere RD, Kappas A, Abraham NG: Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc. Natl. Acad. Sci. USA 91, 5987-5991 (1994)
93. Lee HH, Dadgostar H, Cheng Q, Shu J, Cheng G: NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes. Proc. Natl. Acad. Sci. USA 96, 9136-9141 (1999)
94. Lee PJ, Jiang B-H, Chin BY, Iyer NV, Alam J, Semenza GL, Choi AMK: Hypoxia-inducible factor 1 mediates transcriptional activation of the heme oxygenase-1 gene in response to hypoxia. J. Biol. Chem. 272, 5375-5381 (1997)
95. Lee W, Mitchell P, Tjian R: Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements. Cell 49, 741-752 (1987)
96. Li Y, Jaiswal AK: Regulation of human NAD(P)H:quinone oxidoreductase gene. Role of AP1 binding site contained within human antioxidant response element. J. Biol. Chem. 267, 15097-15104 (1992)
97. Lilienbaum A, Israel A: From calcium to NF-kappa B signaling pathways in neurons. Mol. Cell. Biol. 23, 2680-2698 (2003)
98. Liu J, Ginis I, Spatz M, Hallenbeck JM: Hypoxic preconditioning protects cultured neurons against hypoxic stress via TNF-alpha and ceramide. Am. J. Physiol. Cell Physiol. 278, C144-153 (2000)
99. Liu Y, Kato H, Nakata N, Kogure K: Protection of rat hippocampus against ischemic neuronal damage by pretreatment with sublethal ischemia. Brain Res. 586, 121-124 (1992)
100. Loddick SA, Turnbull AV, Rothwell NJ: Cerebral interleukin-6 is neuroprotective during permanent focal cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 18, 176-179 (1998)
101. Longa EZ, Weinstein PR, Carlson S, Cummins R.: Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 20, 84-91 (1989)
102. Mabuchi T, Kitagawa K, Kuwabara K, Takasawa K, Ohtsuki T, Xia Z, Storm D, Yanagihara T, Hori M, Matsumoto M: Phosphorylation of cAMP response element-binding protein in hippocampal neurons as a protective response after exposure to glutamate in vitro and ischemia in vivo. J. Neurosci. 21, 9204-9213 (2001)
103. Mackay KB, Loddick SA, Naeve GS, Vana AM, Verge GM, Foster AC: Neuroprotective effects of insulin-like growth factor-binding protein ligand inhibitors in vitro and in vivo. J. Cereb Blood Flow Metab. 23, 1160-1167 (2003)
104. Macrae IM, Robinson MJ, Graham DI, Reid JL, McCulloch J: Endothelin-1-induced reductions in cerebral blood flow: dose dependency, time course, and neuropathological consequences. J. Cereb. Blood Flow Metab. 13, 276-284 (1993)
105. Martin-Villalba A, Herr I, Jeremias I, Hahne M, Brandt R, Vogel J, Schenkel J, Herdegen T, Debatin KM: CD95 ligand (Fas-L/APO-1L) and tumor necrosis factor-related apoptosis-inducing ligand mediate ischemia-induced apoptosis in neurons. J. Neurosci. 19, 3809-3817 (1999)
106. Martz D, Rayos G, Schielke GP, Betz AL: Allopurinol and dimethylthiourea reduce brain infarction following middle cerebral artery occlusion in rats. Stroke 20, 488-494 (1989)
107. Matsui K, Fine A, Zhu B, Marshak-Rothstein A, Ju ST: Identification of two NF-kappa B sites in mouse CD95 ligand (Fas ligand) promoter: functional analysis in T cell hybridoma. J Immunol. 161, 3469-3473 (1998)
108. Matsushima K, Hakim AM: Transient forebrain ischemia protects against subsequent focal cerebral ischemia without changing cerebral perfusion. Stroke 26, 1047-152 (1995)
109. Matsushima K, Hogan MJ, Hakim AM: Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J Cereb Blood Flow Metab. 16, 221-226 (1996)
110. Mattson MP, Cheng B, Culwell AR, Esch FS, Lieberburg I, Rydel RE: Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron 10, 243-254 (1993)
111. Mattson MP, Culmsee C, Yu Z, Camandola S: Roles of nuclear factor kappaB in neuronal survival and plasticity. J. Neurochem. 74, 443-456 (2000)
112. Melillo G, Musso T, Sica A, Taylor LS, Cox GW, Varesio L: A hypoxia-responsive element mediates a novel pathway of activation of the inducible nitric oxide synthase promoter. J. Exp. Med. 182, 1683-1693 (1995)
113. Meyer M, Schreck R, Baeuerle PA: H2O2 and antioxidants have opposite effects on activation of NF-kappa B and AP-1 in intact cells: AP-1 as secondary antioxidant-responsive factor. EMBO J. 12, 2005-15 (1993)
114. Mies G, Ishimaru S, Xie Y, Seo K, Hossmann KA: Ischemic thresholds of cerebral protein synthesis and energy state following middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab. 11, 753-761 (1991)
115. Miller BA, Perez RS, Shah AR, Gonzales ER, Park TS, Gidday JM: Cerebral protection by hypoxic preconditioning in a murine model of focal ischemia-reperfusion. Neuroreport 12, 1663-1669 (2001)
116. Miyashita K, Abe H, Nakajima T, Ishikawa A, Nishiura M, Sawada T, Naritomi H: Induction of ischaemic tolerance in gerbil hippocampus by pretreatment with focal ischaemia. Neuroreport 6, 46-48 (1994)
117. Moncayo J, de Freitas GR, Bogousslavsky J, Altieri M, van Melle G: Do transient ischemic attacks have a neuroprotective effect? Neurology 54, 2089-2094 (2000)
118. Mon N, Prager D: Transactivation of the interleukin-1 alpha promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood 87, 3410-3417 (1996)
119. Murphy TH, De Long MJ, Coyle JT: Enhanced NAD(P)H:quinone reductase activity prevents glutamate toxicity produced by oxidative stress. J. Neurochem. 56, 990-995 (1991)
120. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74, 1124-1136 (1986)
121. Nakagomi T, Kirinio T, Kanemitsu H, Tsujita Y, Tamura A: Early recovery of protein synthesis following ischemia in hippocampal neurons with induced tolerance in the gerbil. Acta Neuropatholl (Berl.) 86, 10-15 (1993)
122. Nakano S, Kato H, Kogure K: Neuronal damage in the rat hippocampus in a new model of repeated reversible transient cerebral ischemia. Brain Res. 490, 178-180 (1989)
123. Nakase T, Fushiki S, Naus CC: Astrocytic gap junctions composed of connexin 43 reduce apoptotic neuronal damage in cerebral ischemia. Stroke 34, 1987-1993 (2003)
124. Namura S, Iihara K, Takami S, Nagata I, Kikuchi H, Matsushita K, Moskowitz MA, Bonventre JV, Alessandrini A: Intravenous administration of MEK inhibitor U0126 affords brain protection against forebrain ischemia and focal cerebral ischemia. Proc. Natl. Acad. Sci. USA 98, 11569-11574 (2001)
125. Nawashiro H, Tasaki K, Ruetzler CA, Hallenbeck JM: TNF-alpha pretreatment induces protective effects against focal cerebral ischemia in mice. J. Cereb. Blood Flow Metab. 17, 483-490 (1997)
126. Nishimura M, Sugino T, Nozaki K, Takagi Y, Hattori I, Hayashi J, Hashimoto N, Moriguchi T, Nishida E: Activation of p38 kinase in the gerbil hippocampus showing ischemic tolerance. J. Cereb. Blood Flow Metab. 23, 1052-1059 (2003)
127. Nishio S, Yunoki M, Chen ZF, Anzivino MJ, Lee KS: Ischemic tolerance in the rat neocortex following hypothermic preconditioning. J Neurosurg. 93, 845-851 (2000)
128. Okamoto T, Darbouy M, Brouillet A, Lahuna O, Chobert MN, Laperche Y: Expression of the rat gamma-glutamyl transpeptidase gene from a specific promoter in the small intestine and in hepatoma cells. Biochemistry 33, 11536-11543 (1994)
129. Panahian N, Yoshiura M, Maines MD: Overexpression of heme oxygenase-1 is neuroprotective in a model of permanent middle cerebral artery occlusion in transgenic mice. J. Neurochem. 72, 1187-1203 (1999)
130. Perez-Pinzon MA, Mumford PL, Rosenthal M, Sick TJ: Anoxic preconditioning in hippocampal slices: role of adenosine. Neuroscience 75, 687-694 (1996)
131. Perez-Pinzon MA, Xu GP, Dietrich WD, Rosenthal M, Sick TJ: Rapid preconditioning protects rats against ischemic neuronal damage after 3 but not 7 days of reperfusion following global cerebral ischemia. J. Cereb. Blood Flow Metab. 17, 175-182 (1997)
132. Prass K, Ruscher K, Karsch M, Isaev N, Megow D, Priller J, Scharff A, Dirnagl U, Meisel A: Desferrioxamine induces delayed tolerance against cerebral ischemia in vivo and in vitro. J. Cereb. Blood Flow Metab. 22, 520-525 (2002)
133. Prass K, Scharff A, Ruscher K, Lowl D, Muselmann C, Victorov I, Kapinya K, Dirnagl U, Meisel A: Hypoxia-induced stroke tolerance in the mouse is mediated by erythropoietin. Stroke 34, 1981-1986 (2003)
134. Prass K, Wiegand F, Schumann P, Ahrens M, Kapinya K, Harms C, Liao W, Trendelenburg G, Gertz K, Moskowitz MA, Knapp F, Victorov IV, Megow D, Dirnagl U: Hyperbaric oxygenation induced tolerance against focal cerebral ischemia in mice is strain dependent. Brain Res. 871, 146-150 (2000)
135. Pulsinelli WA, Brierley JB: A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke 10, 267-272 (1979)
136. Relton JK, Rothwell NJ: Interleukin-1 receptor antagonist inhibits ischaemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29, 243-246 (1992)
137. Rhoades KL, Golub SH, Economou JS: The regulation of the human tumor necrosis factor alpha promoter region in macrophage, T cell, and B cell lines. J. Biol. Chem. 267, 22102-22107 (1992)
138. Riccio A, Ahn S, Davenport CM, Blendy JA, Ginty DD: Mediation by a CREB family transcription factor of NGF-dependent survival of sympathetic neurons. Science 286, 2358-2361 (1999)
139. Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC: Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size. Stroke 29, 1020-1030 (1998)
140. Rossen R, Kabat H, Anderson JP: Acute arrest of cerebral circulation in man. Arch. Neurol. Psychiat. 50, 510-528 (1943)
141. Ruscher K, Freyer D, Karsch M, Isaev N, Megow D, Sawitzki B, Priller J, Dirnagl U, Meisel A: Erythropoietin is a paracrine mediator of ischemic tolerance in the brain: evidence from an in vitro model. J. Neurosci. 22, 10291-10301 (2002)
142. Ruscher K, Isaev N, Trendelenburg G, Weih M, Iurato L, Meisel A, Dirnagl U: Induction of hypoxia-inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons. Neurosci. Lett. 254, 117-120 (1998)
143. Sakanaka M, Wen TC, Matsuda S, Masuda S, Morishita E, Nagao M, Sasaki R: In vivo evidence that erythropoietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci. USA 95, 4635-4640 (1998)
144. Sattler R, Tymianski M: Molecular mechanisms of calcium-dependent excitotoxicity. J. Mol. Med. 78, 3-13 (2000)
145. Schabitz WR, Kollmar R, Schwaninger M, Juettler E, Bardutzky J, Scholzke MN, Sommer C, Schwab S: Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke 34, 745-751 (2003)
146. Schabitz WR, Schwab S, Spranger M, Hacke W: Intraventricular brain-derived neurotrophic factor reduces infarct size after focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 17, 500-506 (1997)
147. Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K.: Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc. Natl. Acad. Sci. USA 91, 1672-1676 (1994)
148. Schwartz-Bloom RD, Sah R: γ-Aminobutyric acidA neurotransmission and cerebral ischemia. J. Neurochem. 77, 353-371 (2001)
149. Semenza GL: HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480 (2000)
150. Semenza GL: HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1-3 (2001)
151. Shamloo M, Rytter A, Wieloch T: Activation of the extracellular signal-regulated protein kinase cascade in the hippocampal CA1 region in a rat model of global cerebral ischemic preconditioning. Neuroscience 93, 81-88 (1999)
152. Sharp FR, Lu A, Tang Y, Millhorn DE: Multiple molecular penumbras after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20, 1011-1032 (2000)
153. Shigeno T, Mima T, Takakura K, Graham DI, Kato G, Hashimoto Y, Furukawa S: Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11, 2914-2919 (1991)
154. Siesjö BK: Historical overview. Calcium, ischemia, and death of brain cells. Ann. NY Acad. Sci. 522, 638-661 (1988)
155. Smith ML, Bendek G, Dahlgren N, Rosen I, Wieloch T, Siesjo BK: Models for studying long-term recovery following forebrain ischemia in the rat. 2. A 2-vessel occlusion model. Acta Neurol. Scand. 69, 385-401 (1984)
156. Sommer C, Fahrner A, Kiessling M: [3H] muscimol binding to gamma-aminobutyric acid(A) receptors is upregulated in CA1 neurons of the gerbil hippocampus in the ischemia-tolerant state. Stroke 33, 1698-1705 (2002)
157. Sommer C, Kiessling M: Ischemia and ischemic tolerance induction differentially regulate protein expression of GluR1, GluR2, and AMPA receptor binding protein in the gerbil hippocampus: GluR2 (GluR-B) reduction does not predict neuronal death. Stroke 33, 1093-1100 (2002)
158. Sonnenberg JL, Macgregor-Leon PF, Curran T, Morgan JI: Dynamic alterations occur in the levels and composition of transcription factor AP-1 complexes after seizure. Neuron 3, 359-365 (1989)
159. Stagliano NE, Perez-Pinzon MA, Moskowitz MA, Huang PL: Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J. Cereb. Blood Flow Metab. 19, 757-761 (1999)
160. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J: Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J. Exp. Med. 188, 211-216 (1998)
161. Stroemer RP, Rothwell NJ: Cortical protection by localized striatal injection of IL-1 following cerebral ischemia in the rat. J. Cereb. Blood Flow Metab. 17, 597-604 (1997)
162. Sugino T, Nozaki K, Takagi Y, Hattori I, Hashimoto N, Moriguchi T, Nishida E: Activation of mitogen-activated protein kinases after transient forebrain ischemia in gerbil hippocampus. J. Neurosci. 20, 4506-4514 (2000)
163. Sun Y, Jin K, Xie L, Childs J, Mao XO, Logvinova A, Greenberg DA: VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest. 111, 1843-1851 (2003)
164. Symon L: The relationship between CBF, evoked potentials and the clinical features in cerebral ischaemia. Acta Neurol. Scand. Suppl. 78, 175-190 (1980)
165. Takizawa S, Hirabayashi H, Matsushima K, Tokuoka K, Shinohara Y: Induction of heme oxygenase protein protects neurons in cortex and striatum, but not in hippocampus, against transient forebrain ischemia. J Cereb Blood Flow Metab. 18, 559-569 (1998)
166. Tanaka H, Calderone A, Jover T, Grooms SY, Yokota H, Zukin RS, Bennett MV: Ischemic preconditioning acts upstream of GluR2 down-regulation to afford neuroprotection in the hippocampal CA1. Proc. Natl. Acad. Sci. USA 99, 2362-2367 (2002)
167. Tao X, Finkbeiner S, Arnold DB, Shaywitz AJ, Greenberg ME: Ca2+ influx regulates BDNF transcription by a CREB family transcription factor-dependent mechanism. Neuron 20, 709-726 (1998)
168. Tasaki K, Ruetzler CA, Ohtsuki T, Martin D, Nawashiro H, Hallenbeck JM: Lipopolysaccharide pretreatment induces resistance against subsequent focal cerebral ischemic damage in spontaneously hypertensive rats. Brain Res. 748, 267-270 (1997)
169. Taylor BS, de Vera ME, Ganster RW, Wang Q, Shapiro RA, Morris SM Jr, Billiar TR, Geller DA: Multiple NF-kappaB enhancer elements regulate cytokine induction of the human inducible nitric oxide synthasegene. J. Biol. Chem. 273, 15148-15156 (1998)
170. Teichert AM, Karantzoulis-Fegaras F, Wang Y, Mawji IA, Bei X, Gnanapandithen K, Marsden PA: Characterization of the murine endothelial nitric oxide synthase promoter. Biochim. Biophys. Acta 1443, 352-357 (1998)
171. Tibbies LA, Woodgett JR: The stress-activated protein kinase pathways. Cell Mol. Life Sci. 55, 1230-1254 (1999)
172. Tomida S, Nowak TS, Vass K, Lohr JM, Klatzo I: Experimental model for repetitive ischemic attacks in the gerbil: the cumulative effect of repeated ischemic insults. J. Cereb. Blood Flow Metab. 7, 773-782 (1987)
173. Tomita N, Morishita R, Tomita S, Yamamoto K, Aoki M, Matsushita H, Hayashi S, Higaki J, Ogihara T: Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells. J. Hypertens. 16, 993-1000 (1998)
174. Toosy N, McMorris EL, Grace PA, Mathie RT: Ischaemic preconditioning protects the rat kidney from reperfusion injury. BJU Int. 84, 489-494 (1999)
175. Toyoda T, Kassell NF, Lee KS: Induction of ischemic tolerance and antioxidant activity by brief focal ischemia. Neuroreport 8, 847-851 (1997)
176. Trejo J, Massamiri T, Dent T, Dwji NN, Bayney RM, Brown JH: A direct role of protein kinase C and the transcription factor Jun/AP-1 in the regulation of the Alzheimer's beta-amyloid precursor protein gene. J. Biol. Chem. 269, 21682-21690 (1994)
177. Trendelenburg G, Press K, Priller J, Kapinya K, Policy A, Muselmann C, Ruscher K, Kannbley U, Castell S, Wiegand F, Meisel A, Rosenthal A, Dirnagl U: Serial analysis of gene expression identifies metallothionein II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22, 5879-5888 (2002)
178. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lockeren Campagne M, Ferrera N: VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J. Clin. Invest. 104, 1613-1620 (1999)
179. van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT: 12-O-tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J. Biol. Chem. 269, 6185-6192 (1993)
180. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S: Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9, 2723-2735 (1995)
181. Wada K, Ito M, Miyazawa T, Katoh H, Nawashiro H, Shima K, Chigasaki H: Repeated hyperbaric oxygen induces ischemic tolerance in gerbil hippocampus. Brain Res. 740, 15-20 (1996)
182. Wang X, Xu L, Wang H, Young PR, Gaestel M, Feuerstein GZ: Mitogen-activated protein kinase-activated protein (MAPKAP) kinase 2 deficiency protects brain from ischemic injury in mice. J. Biol. Chem. 277, 43968-43972 (2002)
183. Wang X, Yue TL, Barone FC, White RF, Clark RK, Willette RN, Sulpizio AC, Aiyar NV, Ruffolo RR Jr, Feuerstein GZ: Discovery of adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc. Natl. Acad. Sci. USA 92, 11480-11804 (1995)
184. Wardas J: Neuroprotective role of adenosine in the CNS. Pol. J. Pharmacol. 54, 313-326 (2002)
185. Wegener S, Gottschalk B, Jovanovic V, Knab R, Fiebach JB, Schellinger PD, Kucinski T, Jungehulsing GJ, Brunecker P, Muller B, Banasik A, Amberger N, Wernecke KD, Siebler M, Rother J, Villringer A, Weih M; MRI in Acute Stroke Study Group of the German Competence Network Stroke: Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study. Stroke 35, 616-621 (2004)
186. Weih M, Bergk A, Isaev NK, Ruscher K, Megow D, Riepe M, Meisel A, Victorov IV, Dirnagl U: Induction of ischemic tolerance in rat cortical neurons by 3-nitropropionic acid: chemical preconditioning. Neurosci. Lett. 272, 207-210 (1999)
187. Weih M, Kallenberg K, Bergk A, Dirnagl U, Harms L, Wernecke KD, Einhaupl KM: Attenuated stroke severity after prodromal TIA: a role for ischemic tolerance in the brain? Stroke 30, 1851-1854 (1999)
188. Widmann C, Gibson S, Jarpe MB, Johnson GL: Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180 (1999)
189. Wiegand F, Liao W, Busch C, Castell S, Knapp F, Lindauer U, Megow D, Meisel A, Redetzky A, Ruscher K, Trendelenburg G, Victorov I, Riepe M, Diener HC, Dirnagl U: Respiratory chain inhibition induces tolerance to focal cerebral ischemia. J. Cereb Blood Flow Metab 19, 1229-1237(1999)
190. Wong GH, Elwell JH, Oberley LW, Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58, 923-931 (1989)
191. Wu H, Lozano G: NF-kappa B activation of p53. A potential mechanism for suppressing cell growth in response to stress. J. Biol. Chem. 269, 20067-20074 (1994)
192. Xiong L, Zheng Y, Wu M, Hou L, Zhu Z, Zhang X, Lu Z: Preconditioning with isoflurane produces dose-dependent neuroprotection via activation of adenosine triphosphate-regulated potassium channels after focal cerebral ischemia in rats. Anesth. Analg. 96, 233-237 (2003)
193. Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y, Fong WG, Crocker SJ, Korneluk RG, Robertson GS: Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J. Neurosci. 19, 5026-5033 (1999)
194. Xu P, Huecksteadt TP, Hoidal JR: Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics 34, 173-180 (1996)
195. Yamamoto K, Arakawa T, Ueda N, Yamamoto S: Transcriptional roles of nuclear factor kappa B and nuclear factor-interleukin-6 in the tumor necrosis factor alpha-dependent induction of cyclooxygenase-2 in MC3T3-E1 cells. J. Biol. Chem. 270, 31315-31320 (1995)
196. Yankner BA, Dawes LR, Fisher S, Villa-Komaroff L, Oster-Granite ML, Neve RL: Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 245, 417-420 (1989)
197. Yao KS, O'Dwyer PJ: Involvement of NF-kappa B in the induction of NAD(P)H:quinone oxidoreductase (DT-diaphorase) by hypoxia, oltipraz and mitomycin C. Biochem. Pharmacol. 49, 275-282 (1995)
198. Yuan HB, Huang Y, Zheng S, Zuo Z: Hypothermic preconditioning increases survival of purkinje neurons in rat cerebellar slices after an in vitro simulated ischemia. Anesthesiology 100, 331-337 (2004)
199. Zaman K, Ryu H, Hall D, O'Donovan K, Lin KI, Miller MP, Marquis JC, Baraban JM, Semenza GL, Ratan RR: Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin. J. Neurosci. 19, 9821-9830 (1999)
200. Zong WX, Edelstein LC, Chen C, Bash J, Gelinas C: The prosurvival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-kappaB that blocks TNFalpha-induced apoptosis. Genes. Dev. 13, 382-387 (1999)